Trian, Solventum
M spin-off Solventum forecast annual profit above analyst estimates on Thursday, betting on strong sales of its wound care and surgical sterilization products.
The most notable increase was Solventum Corp (NYSE:SOLV), with an additional 1,336,564 shares, bringing the total to 8,462,819 shares. This adjustment represents a significant 18.76% increase in share ...
Nelson Peltz’s Trian Partners sent a letter to the shareholders of Solventum (SOLV), saying the company trades at a discount to peers and 3M (MMM), Scott Wapner of CNBC reports. Trian believes ...
Thermo Fisher’s release goes on to suggest that it believes it can more than double the profitability of Purification & Filtration under its corporate umbrella, relative to the business’ current ...
Solventum Corporation (NYSE:SOLV) is a spinoff from 3M Company (MMM) and is currently facing activist investor pressure. Nelson Peltz, a billionaire investor, has a 5% stake in the company and ...
Solventum Shares Are Up Today ... its bioproduction portfolio with expected long-term growth. Vandana Singh Nelson Peltz's Trian Fund Management Reshaped Portfolio Ahead Of Presidential Election ...
Unilever's board, which includes billionaire activist investor Nelson Peltz, was unified in its decision to oust CEO Hein ...
Thermo Fisher Scientific said Tuesday it is buying Solventum’s purification and filtration business, confirming an earlier ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback